Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Cancer

New pancreatic cancer drug nearly doubles survival time in patients

Pancreatic cancer is the only cancer with a five-year survival rate that’s below 20%

The Independent UK

Department of Health retracts claim sunbeds are as dangerous as smoking

DHSC corrects statements after regulator intervenes as experts say smoking causes far more cancer cases

The Guardian - UK

867-5309: number from 1980s hit song Jenny now routes callers to cancer support

Music’s most famous number is being repurposed to offer resources and support for patients and caregivers

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

A 'vital' new drug for hot flushes is now available: what does this mean for UK women?

Veoza, also known as fezolinetant, was first approved a couple of years ago - and is now available for prescription for those eligible

Woman & Home

Draft rare cancers law offers hope to those with incurable brain tumours

Abi Feltham was diagnosed with a brain tumour in May 2024 and was told she has 15 years to live.

Evening Standard

“These chemicals are not just additives; they may be migrating from the headphones into our body”: Research shows nearly all headphones contain chemicals that are dangerous to human health

And they could be absorbed into your skin via sweat

MusicRadar

Victims of cancer-linked pregnancy drug to demand public inquiry into ‘silent scandal’

The victims are due to meet with Health Secretary West Streeting on Monday

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

London firefighters exposed to toxic chemicals face higher risk of cancer, report warns

Around one in 25 of the firefighters surveyed by the FBU have reported being diagnosed with cancer

Evening Standard

Patients with ‘invisible’ cancer being turned away by doctors

Neuroendocrine cancer impacts more than 6,000 people a year in England

The Independent UK

Financial toll hangs heavy over cancer patients

Australians undergoing cancer treatment are facing out-of-pocket expenses even when accessing the public healthcare system, data reveals.

AAP

Cancer drugs among nearly 400 medicines at risk of shortage in UK

Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable

The Independent UK

King’s support at Sandringham charity parkrun ‘means the world’

Charles cheered on participants on Saturday morning and chatted with local members of Move Against Cancer’s 5K Your Way group.

Evening Standard

One in four school leavers have higher cancer risk because they skipped this vaccine

A ‘concerning’ number of students are missing out on the crucial HPV vaccines, says health minister

The Independent UK

Study finds no stomach cancer link to long-term acid reflux drugs

Early research on the links was ‘hampered by several methodological limitations’ says researchers

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Scotland first part of UK to approve ‘cutting edge’ treatment for stomach cancer

The Scottish Medicines Consortium has approved zolbetuximab – to be used together with chemotherapy – to treat those with advanced stomach cancer.

The Independent UK

United Airlines technician with Stage 4 cancer fired during chemotherapy session, lawsuit says

Exclusive: ‘No one should have to choose between their health and their livelihood,’ a lawyer for 737 mechanic Hasan Syed told The Independent

The Independent UK

Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder

A Minnesota jury has awarded $65.5 million to a woman who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing mesothelioma

Woman & Home

'Early diagnosis quite simply is key' - King Charles's plea as he shares rare health update

'Your life - or the life of someone you love - may depend on it'

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

King Charles III to speak about his cancer treatment, recovery on TV show promoting early screening

King Charles III will speak about his cancer diagnosis and recovery during a TV broadcast on Friday as the monarch continues to use his personal story to encourage others to get the early screening that can boost their chances of survival

Benzinga

BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co. (NYSE:BMY) on Tuesday shared the first interim data from a global randomized Phase 2 trial of pumitamig (BNT327/BMS986545) plus chemotherapy for locally advanced/metastatic triple-negative breast cancer (TNBC) irrespective of PD-L1 expression levels.

Benzinga

Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial

Exicure, Inc. (NASDAQ:XCUR) stock is trading higher on Tuesday. Its session volume was 13.62 million, compared with the average volume of 151.41 thousand, according to data from Benzinga Pro.

Benzinga

Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) on Monday presented updated and expanded data from the ongoing CARDINAL trial of TERN-701 in previously treated chronic myeloid leukemia (CML) patients at the American Society of Hematology Annual Meeting and Exposition.

Benzinga

Why Is Arcellx Stock Surging Today?

Arcellx Inc. (NASDAQ:ACLX) shared new data on Saturday from its pivotal Phase 2 iMMagine-1 study of anitocabtagene autoleucel (anito-cel) for relapsed or refractory multiple myeloma (RRMM).

Benzinga

Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors

Pliant Therapeutics, Inc. (NASDAQ:PLRX) is capturing attention with promising trial results for its cancer therapy, despite a sharp stock decline.

Benzinga

Janux Therapeutics Stock Hits 52-Week Low After Trial Update

Janux Therapeutics Inc. (NASDAQ:JANX) stock hit a 52-week low on Tuesday after the company released updated interim data for its JANX007 Phase 1 program for metastatic castration-resistant prostate cancer (mCRPC).

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the American Cancer Society

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.